Rozenberg, S.
Al-Daghri, N.
Aubertin-Leheudre, M.
Brandi, M.-L.
Cano, A.
Collins, P.
Cooper, C.
Genazzani, A. R.
Hillard, T.
Kanis, J.A.
Kaufman, J.-M.
Lambrinoudaki, I.
Laslop, A.
McCloskey, E.
Palacios, S.
Prieto-Alhambra, D.
Reginster, J.-Y.
Rizzoli, R.
Rosano, G.
Trémollieres, F.
Harvey, N.C. http://orcid.org/0000-0002-8194-2512
Article History
Received: 10 March 2020
Accepted: 4 May 2020
First Online: 8 July 2020
Compliance with ethical standards
:
: N. Al-Daghri has no disclosures. M. Aubertin-Leheudre has no disclosures. M-L. Brandi reports honoraria from Amgen, Bruno Farmaceutici, Calcilytix and Kyowa Kirin; academic grants and/or speaker fees from Abiogen, Alexion, Amgen, Bruno Farmaceutici, Eli Lilly, Kyowa Kirin, MSD, NPS, Servier, Shire and SPA; and consultancy fees from Alexion, Bruno Farmaceutici, Kyowa Kirin, Servier and Shire outside the scope of the submitted work. A. Cano reports consultancy, honoraria and lecture fees from Theramex and Italfarmaco outside the scope of the submitted work. P. Collins reports consultancy, lecture fees and honoraria from Eli Lilly, Abbott, Novo Nordisk and Bayer outside the scope of the submitted work. C. Cooper reports consultancy, lecture fees and honoraria from AMGEN, GSK, Alliance for Better Bone Health, MSD, Eli Lilly, Pfizer, Novartis, Servier, Medtronic and Roche outside the scope of the submitted work. A. Genazzani has no disclosures. N. Harvey reports consultancy, lecture fees and honoraria from Alliance for Better Bone Health, AMGEN, MSD, Eli Lilly, Servier, Shire, UCB, Kyowa Kirin, Consilient Healthcare, Radius Health and Internis Pharma outside the scope of the submitted work. T. Hillard reports lecture fees and honoraria from Shionogi, Novo Nordisk and Theramex outside the scope of the submitted work. J. Kanis reports grants from UCB, grants from Amgen and grants from Radius Health outside the submitted work, and Dr. Kanis is a member of the National Osteoporosis Guideline Group (NOGG) and the principal architect of FRAX but derives no financial benefit. J-M. Kaufman is board member (treasurer) of ESCEO. I. Lambrinoudaki has no disclosures. A. Laslop has no disclosures. E. McCloskey reports consultant/advisor/speaker fees or research funding from Agnovos, Amgen, AstraZeneca, Consilient Healthcare, Fresenius Kabi, GSK, Hologic, I3 Innovus, Internis, Lilly, Merck, MRC, Novartis, Pfizer, Roche, Sanofi-Aventis, Servier, Synexus, UCB, Unilever, Versus Arthritis and Warner Chilcott outside the scope of the submitted work. S. Palacios has received consultancy, lecture fees, honoraria and grants from Serelys, Pfizer, Amgen, Gedeon Ritcher, Exeltis, Bayer Schering, MSD, Procare Health, Mylan and Shionogi outside the scope of the submitted work. D. Prieto-Alhambra’s research group reports research grants from Amgen, Servier and UCB; speaker tuition fees and advisory or consultancy fees (all paid to his department) from Amgen and UCB outside the scope of the submitted work. J-Y. Reginster reports consulting fees or paid advisory boards from IBSA-Genevrier, Mylan, Radius Health and Pierre Fabre; lecture fees when speaking at the invitation of sponsor from IBSA-Genevrier, Mylan, CNIEL and Dairy Research Council (DRC); and grant support from Industry (All through Institution) from IBSA-Genevrier, Mylan, CNIEL and Radius Health outside the scope of the submitted work. R. Rizzoli reports fees for advisory board or lectures from Abiogen, Amgen, CNIEL, Danone, Echolight, Effryx, EMF, Mithra, Mylan, Nestlé, ObsEva, Radius Health, Rejuvenate, Sandoz and Theramex outside the scope of the submitted work. G. Rosano has no disclosures. S. Rozenberg reports consultancy, lecture fees, honoraria and grants from Mylan, Abbott, Gedeon-Richter, UCB and Amgen outside the scope of the submitted work. F. Trémollieres reports lecture and/or consultancy fees from Amgen, Arrow, Lilly France and Theramex and non-financial support for meeting from Besins Healthcare France outside the scope of the submitted work.
: This review article reports previously published findings and does not include any new research.